[Federal Register Volume 78, Number 244 (Thursday, December 19, 2013)]
[Notices]
[Page 76841]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-30146]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2008-D-0150]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Guidance for Industry on
Hypertension Indication: Drug Labeling for Cardiovascular Outcome
Claims
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Guidance for Industry on
Hypertension Indication: Drug Labeling for Cardiovascular Outcome
Claims'' has been approved by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville,
MD 20850, [email protected].
SUPPLEMENTARY INFORMATION: On September 10, 2013, the Agency submitted
a proposed collection of information entitled ``Guidance for Industry
on Hypertension Indication: Drug Labeling for Cardiovascular Outcome
Claims'' to OMB for review and clearance under 44 U.S.C. 3507. An
Agency may not conduct or sponsor, and a person is not required to
respond to, a collection of information unless it displays a currently
valid OMB control number. OMB has now approved the information
collection and has assigned OMB control number 0910-0670. The approval
expires on December 31, 2016. A copy of the supporting statement for
this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.
Dated: December 12, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-30146 Filed 12-18-13; 8:45 am]
BILLING CODE 4160-01-P